Inspire Medical Systems, Inc. (INSP)
NYSE$162.16
Market Cap
$4.81B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
648 of 924
Rank in Industry
80 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
INSP Insider Trading Activity
INSP Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $25,543,609 | 17 | 100 |
Related Transactions
| McCormick Shawn | director | 0 | $0 | 1 | $176,000 | $-176,000 |
| Griffin Jerry C | director | 0 | $0 | 3 | $223,650 | $-223,650 |
| Buchholz Richard | Chief Financial Officer | 0 | $0 | 1 | $3.45M | $-3.45M |
| Rondoni John | Chief Technology Officer | 0 | $0 | 7 | $4.03M | $-4.03M |
| Herbert Timothy P. | CEO and President | 0 | $0 | 1 | $8.2M | $-8.2M |
| Ban Randy | Chief Commercial Officer | 0 | $0 | 4 | $9.46M | $-9.46M |
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The …
Insider Activity of Inspire Medical Systems, Inc.
Over the last 12 months, insiders at Inspire Medical Systems, Inc. have bought $0 and sold $25.54M worth of Inspire Medical Systems, Inc. stock.
On average, over the past 5 years, insiders at Inspire Medical Systems, Inc. have bought $15,350 and sold $67.45M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100 shares for transaction amount of $15,350 was made by Sparks Charisse Y (Chief Medical Officer) on 2023‑10‑12.
List of Insider Buy and Sell Transactions, Inspire Medical Systems, Inc.
| 2025-03-03 | Sale | Rondoni John | Chief Technology Officer | 2,287 0.0078% | $185.60 | $424,467 | -4.01% | |
| 2025-03-03 | Sale | Ban Randy | See Remarks | 3,947 0.0136% | $185.84 | $733,496 | -4.01% | |
| 2025-02-13 | Sale | Ban Randy | See Remarks | 25,584 0.0846% | $183.50 | $4.69M | -3.73% | |
| 2025-02-11 | Sale | Rondoni John | Chief Technology Officer | 583 0.0018% | $170.49 | $99,396 | +2.07% | |
| 2025-01-07 | Sale | Rondoni John | Chief Technology Officer | 58 0.0002% | $215.00 | $12,470 | -14.87% | |
| 2024-11-01 | Sale | Rondoni John | Chief Technology Officer | 8,703 0.0296% | $193.47 | $1.68M | -1.64% | |
| 2024-09-09 | Sale | McCormick Shawn | director | 800 0.0028% | $220.00 | $176,000 | -9.83% | |
| 2024-09-09 | Sale | Rondoni John | Chief Technology Officer | 31 0.0001% | $215.00 | $6,665 | -9.83% | |
| 2024-08-22 | Sale | Rondoni John | Chief Technology Officer | 5,000 0.0171% | $189.83 | $949,143 | +2.34% | |
| 2024-08-16 | Sale | Ban Randy | Chief Commercial Officer | 4,861 0.0158% | $188.55 | $916,549 | +1.04% | |
| 2024-08-15 | Sale | Ban Randy | Chief Commercial Officer | 16,139 0.0538% | $193.10 | $3.12M | +0.37% | |
| 2024-04-17 | Sale | Buchholz Richard | Chief Financial Officer | 15,000 0.0468% | $230.03 | $3.45M | -22.97% | |
| 2024-04-01 | Sale | Herbert Timothy P. | CEO and President | 40,000 0.1323% | $205.09 | $8.2M | -10.14% | |
| 2024-04-01 | Sale | Griffin Jerry C | director | 32 0.0001% | $213.99 | $6,848 | -10.14% | |
| 2024-03-25 | Sale | Griffin Jerry C | director | 554 0.0018% | $197.81 | $109,587 | -8.13% | |
| 2024-03-22 | Sale | Rondoni John | Chief Technology Officer | 4,387 0.0146% | $194.40 | $852,849 | -4.50% | |
| 2024-03-18 | Sale | Griffin Jerry C | director | 554 0.0018% | $193.53 | $107,216 | -5.27% | |
| 2024-03-11 | Sale | Griffin Jerry C | director | 554 0.0019% | $198.05 | $109,720 | -3.99% | |
| 2024-03-01 | Sale | Griffin Jerry C | director | 554 0.0018% | $179.44 | $99,410 | +3.21% | |
| 2024-02-29 | Sale | Rondoni John | Chief Technology Officer | 8,605 0.0289% | $179.25 | $1.54M | +5.73% |
Total: 256
*Gray background shows transactions not older than one year
Insider Historical Profitability
84.81%
| Herbert Timothy P. | CEO and President | 63658 0.2146% | $10.32M | 1 | 30 | +89.73% |
| Buchholz Richard | Chief Financial Officer | 28271 0.0953% | $4.58M | 1 | 19 | +89.73% |
| McCormick Shawn | director | 23140 0.078% | $3.75M | 1 | 1 | +89.73% |
| Ban Randy | See Remarks | 7259 0.0245% | $1.18M | 1 | 36 | +89.73% |
| Amzak Health Investors, LLC | 10 percent owner | 1497043 5.0457% | $242.76M | 1 | 0 | +89.73% |
*Gray background shows insiders who have made transactions during last year
INSP Institutional Investors: Active Positions
| Increased Positions | 184 | +45.89% | 5M | +13.51% |
| Decreased Positions | 174 | -43.39% | 4M | -12.21% |
| New Positions | 63 | New | 2M | New |
| Sold Out Positions | 48 | Sold Out | 701,728 | Sold Out |
| Total Postitions | 411 | +2.49% | 34M | +1.29% |
INSP Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $779,725.00 | 14% | 4.2M | +83,184 | +2.02% | 2024-12-31 |
| Vanguard Group Inc | $606,946.00 | 10.9% | 3.27M | +38,219 | +1.18% | 2024-12-31 |
| Fmr Llc | $467,600.00 | 8.4% | 2.52M | -428,282 | -14.53% | 2024-12-31 |
| Wasatch Advisors Lp | $245,306.00 | 4.41% | 1.32M | -1,705 | -0.13% | 2024-12-31 |
| Baillie Gifford & Co | $233,102.00 | 4.19% | 1.26M | -110,830 | -8.11% | 2024-12-31 |
| State Street Corp | $197,124.00 | 3.54% | 1.06M | +12,362 | +1.18% | 2024-12-31 |
| William Blair Investment Management, Llc | $167,516.00 | 3.01% | 902,611 | -3,738 | -0.41% | 2024-12-31 |
| Dragoneer Investment Group, Llc | $161,669.00 | 2.9% | 871,110 | +871,110 | New | 2024-12-31 |
| Invesco Ltd. | $147,188.00 | 2.64% | 793,080 | +99,030 | +14.27% | 2024-12-31 |
| Morgan Stanley | $108,501.00 | 1.95% | 584,628 | +221,321 | +60.92% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.